glp-1 nejm trial data on orforglipron showed meaningful weight loss over 72 weeks, with the highest dose producing much larger reductions than placebo. That is why oral drugs suddenly look like a @nejm correct today’s review of

If this comes back normal but you still feel unwell, don't be discouraged

This was subsequently updated in Dec 2020 to include liraglutide for the treatment of obesity in adolescents between 12 to 17 years of age The starting dose of liraglutide is 0.6 mg once each day for 1 week and increased weekly to a maintenance dose of 3 mg once each day

Why its notable: human trials show that CJC-1295 raises growth hormone (GH) and insulin-like growth factor (IGF-1) levels in controlled settings, when used with appropriate supervision

Of course, Tirzepatide is an incredible molecule that's changing the lives of millions of people around the world, but we've been working hard on follow on pipeline products as well. However, Eli Lilly isnt ignoring the upcoming pharma landscape

Dr Ben Lynch book Dirty genes Detoxification 3